Macquarie Group LTD Enovis Corp Transaction History

Macquarie Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$51.65 - $65.54 $75,460 - $95,753	-1,461 Reduced 1.2%	120,532 $6.36 Million
Q2 2023 Aug 14, 2023	BUY	$52.7 - $64.12 $887,520 - $1.08 Million	16,841 Added 16.02%	121,993 $7.82 Million
Q1 2023 May 15, 2023	SELL	$49.5 - $65.92 $151,915 - $202,308	-3,069 Reduced 2.84%	105,152 $5.62 Million
Q4 2022 Feb 21, 2023	SELL	$44.83 - $57.43 $578,620 - $741,249	-12,907 Reduced 10.66%	108,221 $5.79 Million
Q3 2022 Nov 14, 2022	SELL	$46.07 - $60.1 $70,855 - $92,433	-1,538 Reduced 1.25%	121,128 $5.61 Million
Q2 2022 Aug 15, 2022	BUY	$55.0 - $70.47 $6.75 Million - $8.64 Million	122,666 New	122,666 $6.75 Million

310

60.2M

1.68M

693K

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.38B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.